Kingswood Wealth Advisors LLC Takes $780,000 Position in Astera Labs, Inc. $ALAB

Kingswood Wealth Advisors LLC purchased a new position in shares of Astera Labs, Inc. (NASDAQ:ALAB) during the 3rd quarter, Holdings Channel reports. The institutional investor purchased 3,983 shares of the company’s stock, valued at approximately $780,000.

Several other hedge funds and other institutional investors have also recently bought and sold shares of ALAB. Oliver Lagore Vanvalin Investment Group acquired a new stake in Astera Labs during the second quarter valued at approximately $29,000. Bernard Wealth Management Corp. bought a new stake in shares of Astera Labs in the 2nd quarter valued at approximately $36,000. Clearstead Trust LLC increased its holdings in shares of Astera Labs by 46,100.0% in the 2nd quarter. Clearstead Trust LLC now owns 462 shares of the company’s stock valued at $42,000 after acquiring an additional 461 shares during the last quarter. Advisors Asset Management Inc. raised its position in shares of Astera Labs by 68.6% during the 2nd quarter. Advisors Asset Management Inc. now owns 477 shares of the company’s stock valued at $43,000 after acquiring an additional 194 shares in the last quarter. Finally, Manchester Capital Management LLC lifted its stake in Astera Labs by 141.5% during the second quarter. Manchester Capital Management LLC now owns 483 shares of the company’s stock worth $44,000 after purchasing an additional 283 shares during the last quarter. 60.47% of the stock is owned by institutional investors.

Analyst Ratings Changes

ALAB has been the subject of several recent research reports. Weiss Ratings reiterated a “hold (c-)” rating on shares of Astera Labs in a research note on Wednesday, October 8th. Raymond James Financial initiated coverage on shares of Astera Labs in a research report on Friday, November 21st. They set a “hold” rating for the company. JPMorgan Chase & Co. increased their price objective on shares of Astera Labs from $180.00 to $215.00 and gave the stock an “overweight” rating in a research note on Wednesday, November 5th. Morgan Stanley restated an “overweight” rating and issued a $210.00 target price on shares of Astera Labs in a research note on Wednesday, December 3rd. Finally, Zacks Research cut Astera Labs from a “strong-buy” rating to a “hold” rating in a research report on Monday, October 6th. One equities research analyst has rated the stock with a Strong Buy rating, fifteen have issued a Buy rating and eight have assigned a Hold rating to the stock. Based on data from MarketBeat.com, Astera Labs presently has a consensus rating of “Moderate Buy” and an average price target of $188.17.

Astera Labs Stock Up 3.8%

Astera Labs stock opened at $162.61 on Friday. The firm has a 50-day moving average price of $159.79 and a two-hundred day moving average price of $163.33. The firm has a market capitalization of $27.46 billion, a price-to-earnings ratio of 146.50, a PEG ratio of 2.22 and a beta of 1.50. Astera Labs, Inc. has a 52-week low of $47.13 and a 52-week high of $262.90.

Astera Labs (NASDAQ:ALAB) last announced its quarterly earnings results on Tuesday, November 4th. The company reported $0.49 EPS for the quarter, beating the consensus estimate of $0.39 by $0.10. The company had revenue of $230.58 million for the quarter, compared to analyst estimates of $206.42 million. Astera Labs had a net margin of 27.50% and a return on equity of 13.48%. Astera Labs’s revenue was up 103.9% compared to the same quarter last year. During the same quarter last year, the business earned $0.23 earnings per share. Astera Labs has set its Q4 2025 guidance at 0.50-0.510 EPS. Research analysts expect that Astera Labs, Inc. will post 0.34 earnings per share for the current year.

Insider Transactions at Astera Labs

In other news, General Counsel Philip Mazzara sold 4,620 shares of the stock in a transaction on Monday, November 17th. The stock was sold at an average price of $144.69, for a total value of $668,467.80. Following the completion of the transaction, the general counsel owned 147,040 shares of the company’s stock, valued at approximately $21,275,217.60. This represents a 3.05% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. Also, Director Manuel Alba sold 150,000 shares of Astera Labs stock in a transaction dated Monday, December 1st. The shares were sold at an average price of $166.18, for a total transaction of $24,927,000.00. Following the sale, the director owned 1,574,498 shares in the company, valued at approximately $261,650,077.64. This represents a 8.70% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders sold 576,936 shares of company stock worth $87,409,540 over the last quarter. Insiders own 12.50% of the company’s stock.

Astera Labs Profile

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.